Results 251 to 260 of about 79,448 (358)

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Engineering stable Amlodipine suspensions for flexible compounding at King Khaled University Hospital. [PDF]

Saudi Pharm J
Elzayat E, Alotaibi HF, Al-Agamy MH, Alharabi LA, Alhuzani MR.   +4 more
europepmc   +1 more source

Afton Central School District and the Afton Non-Instructional Employees Association (2000) [PDF]

, 2000

core   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. [PDF]

J Am Acad Orthop Surg Glob Res Rev
Rahman OF, Lee SJ, Seeds WA.
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Evolution of the Military Health System compounded drugs utilization and management. [PDF]

J Manag Care Spec Pharm
Robertson T, Wong-Flores J, Raisor TS, Shakes L.   +3 more
europepmc   +1 more source

Comparative QSAR‐ and Fragments Distribution Analysis of Drugs, Druglikes, Metabolic Substances, and Antimicrobial Compounds.

, 2006
Emre Karakoç, S. Cenk Sahinalp, Artem Cherkasov   +2 more
openalex   +2 more sources